GEN Exclusives

More »

GEN News Highlights

More »
Oct 11, 2006

Bioactive Material Completes Proof-of-Concept Studies

  • NovaThera and Pharming completed proof-of-concept studies designed to develop a new generation of bioactive materials. These materials are based on a fusion of the two companies’ technologies —TheraGlass™ (a nonceramic glass) and recombinant human proteins.

    TheraGlass-rH (TheraGlass with recombinant human proteins) has the potential to extend the therapeutic potential from transgenic technologies into the arena of medical devices and materials technologies, the companies report. The new materials can be used for the localized delivery of therapeutic proteins and for developing devices, such as stents and catheters.

    The initial focus is on stents containing materials able to release recombinant human proteins, such as collagen, fibrinogen, lactoferrin, and C1 inhibitor.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using Pet Dogs with Cancer in Preclinical Trials

Do you agree that pet dogs with cancer should be used in early cancer drug trials?

More »